Myriad Genetics
MYGN
#7348
Rank
NZ$0.93 B
Marketcap
NZ$9.86
Share price
0.71%
Change (1 day)
25.57%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -NZ$0.64 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are NZ$0.82 Billion. In 2025 the company made an earning of -NZ$0.67 Billion a decrease over its 2024 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.64 Billion-3.98%
2025 -NZ$0.67 Billion218.91%
2024 -NZ$0.21 Billion-53.49%
2023 -NZ$0.45 Billion88.72%
2022 -NZ$0.24 Billion172.08%
2021 -NZ$87.35 Million
2019 -NZ$45.49 Million-175.14%
2018 NZ$60.53 M-70.81%
2017 NZ$0.20 B22.22%
2016 NZ$0.16 B-38.8%
2015 NZ$0.27 B-6.12%
2014 NZ$0.29 B-41.07%
2013 NZ$0.50 B46.67%
2012 NZ$0.34 B15.84%
2011 NZ$0.29 B17.6%
2010 NZ$0.25 B-15.96%
2009 NZ$0.29 B
2007 -NZ$72.09 Million40.96%
2006 -NZ$51.14 Million
2003 -NZ$59.39 Million34.8%
2002 -NZ$44.06 Million89.21%
2001 -NZ$23.29 Million3.93%
2000 -NZ$22.41 Million21.76%
1999 -NZ$18.4 Million-25.61%
1998 -NZ$24.74 Million38.83%
1997 -NZ$17.82 Million-24.26%
1996 -NZ$23.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
NZ$14.07 B-2,208.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-NZ$0.32 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.66 B-199.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$60.48 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$0.38 B-157.59%๐Ÿ‡บ๐Ÿ‡ธ USA